Comparative analysis of immunosuppressive therapies for myelin oligodendrocyte glycoprotein antibody-associated optic neuritis: a cohort study.
Lindan XieHuanfen ZhouHonglu SongMingming SunMo YangYing Meng LaiQuangang XuShihui WeiPublished in: The British journal of ophthalmology (2021)
This study provides Class III evidence that both MMF and RTX may lower disease activity in patients with MOG-ON, and RTX showed better tolerability than MMF. However, observation after a single attack remains a good option because less than half of patients not on treatment suffered a relapse.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- ejection fraction
- rheumatoid arthritis patients
- newly diagnosed
- ankylosing spondylitis
- peritoneal dialysis
- juvenile idiopathic arthritis
- open label
- clinical trial
- patient reported outcomes
- optical coherence tomography
- white matter
- study protocol
- optic nerve